logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Repros Jumps on Positive Drug Trials

By  +Follow September 17, 2013 8:01AM
Share:
Tickers Mentioned:

Shares in Texas pharma Repros Therapeutics, Inc. (RPRX) gapped up over 30 percent in early morning trading before settling into gains of just over 10 percent on heavy volume as the day wore on. The spike, driven by positive topline results from the most recent study on its drug Androxal® reported after close on Monday, pushed Repros stock to a new 52-week high.

Positive results for Androxal

Androxal is being developed for men of reproductive age with low testosterone due to secondary hypogonadism, which is also associated with obesity and could be among the most common causes of low testosterone. Repros reported that Andorxal met both co-primary endpoints in its second pivotal study, with 81 percent of subjects using the drug experiencing normalized testosterone and no 24-hour average testosterone levels outside of normal ranges. Androxal, which is in a class similar to Sanofi’s (SNY) Clomid®, could receive a strong share of the testosterone replacement therapy (TRT) market because it could also help preserve male fertility while being administered orally, making it significantly more convenient than testosterone replacement injections.  

Possible Sale

Brean Capital initiated coverage of Repros in July of this year, calling it a buy and setting a price target of $32. At the time, analyst Jonathan Aschoff said “Its lead compound Androxal is being evaluated in a Phase 3 program for secondary hypogonadism with results in 4Q13 and 2Q14, which in our view would be key investment catalysts, and we project Androxal launch in mid-2015.” Now, Brean is citing these positive results as a reason for optimism, as well as reports that management may have interest in selling the company. Brean estimated the sell-price potentially reaching $40 a share, in the event that the sale goes down.

In addition to Andorxal, Repros currently has female reproductive drug Proellex® in the pipeline, intended for use in uterine fibroids and endometriosis. “The vaginal formulation of Proellex (Proellex-V) will enter Phase 2b in 2H13 for uterine fibroids with an NDA submission expected in 2016. All compounds are protected by U.S. patents," said Aschoff in July.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for RPRX
Don Fishback
31 Oct 14 04:34:47
Negative Implied Borrow Rate $XONE, $RPRX, $GPRO, $ANV, $RMTI http://t.co/UyntP3LT9Z
OptionApps
31 Oct 14 04:34:47
Negative Implied Borrow Rate $XONE, $RPRX, $GPRO, $ANV, $RMTI http://t.co/Old3lagTLP
Bio Penny Picks
31 Oct 14 04:12:52
$RPRX Will be good today, expecting some good moves up and down.
Stockaholics
31 Oct 14 01:53:38
Our Penny Stock Newsletter Alert On MGON Closed up 112.5% Today! Major News: http://t.co/dvxYQnSJab $ANAC $ACTV $RPRX
Stockaholics
30 Oct 14 20:22:16
Our Penny Stock Newsletter Alert On MGON Closed up 112.5% Today! Major News: http://t.co/dvxYQnSJab $ANAC $ACTV $RPRX
DailyStockPicks
30 Oct 14 18:16:12
Partner Jet $PJT.V is up 183% this week after Q3 release with much more room to increase. Find out why: http://t.co/MEpEjkCm4H $RGLS $RPRX
Dan Kee
30 Oct 14 16:52:15
$RPRX Over 7 this starts to get fun. Low floater 13 mill I think with 5 mill short. Probably will squeeze around 8ish pinball until then
A. Vespasian
30 Oct 14 16:47:43
RT @StockSignaling: Top Stocks (By Trading Liquidity): $GBX $SWHC $EOX $REXX $GPRE $AEGR $NLNK $JAKK $ANGI $BWLD $JNS $ADHD $CSLT $RPRX $DD…
Stock Signaling
30 Oct 14 16:31:20
Top Stocks (By Trading Liquidity): $GBX $SWHC $EOX $REXX $GPRE $AEGR $NLNK $JAKK $ANGI $BWLD $JNS $ADHD $CSLT $RPRX $DDD #swingtrading #spy
ALittleLonger
30 Oct 14 14:36:01
RT @StockSignaling: Top Stocks (By Trading Liquidity): $GBX $SWHC $EOX $REXX $GPRE $AEGR $NLNK $JAKK $ANGI $BWLD $JNS $ADHD $CSLT $RPRX $DD…
Stock Signaling
30 Oct 14 13:31:27
Top Stocks (By Trading Liquidity): $GBX $SWHC $EOX $REXX $GPRE $AEGR $NLNK $JAKK $ANGI $BWLD $JNS $ADHD $CSLT $RPRX $DDD #spy #swingtrading
Stocks Pastor
30 Oct 14 13:29:24
upcoming events: $RPRX, $RMTI
Leilani Pips
30 Oct 14 13:12:05
AFTER HOURS IN $RPRX $GPRO $SAM $ALK
rich rich
30 Oct 14 13:07:03
@ACInvestorBlog thanks for a call $rprx,
Leilani Pips
30 Oct 14 13:00:31
$RPRX for morning gap
rich rich
30 Oct 14 12:59:10
$RPRX hod
 Luke Murray
30 Oct 14 12:56:08
$RPRX in 6.73 for #gapplay
StockSpotter
30 Oct 14 10:35:55
$RPRX up 0.9% to 6.50 after bullish trade setup #stocks #options #trading http://t.co/lvnpOfbshL
Stockaholics
30 Oct 14 10:21:04
VIICQ Closed up 75% Yesterday! Special Update: http://t.co/8A33lxh1RR $ANAC $ACTV $RPRX
stockblaster14
30 Oct 14 07:32:30
Repros Therapeutics Inc (RPRX) 6.41 $RPRX Repros to Webcast Investor and Analyst Day on October 31st GlobeNews http://t.co/PGCiNnXsO7
Stock Signaling
30 Oct 14 07:02:17
Top Stocks (By Trading Liquidity): $GBX $SWHC $EOX $REXX $GPRE $AEGR $NLNK $JAKK $ANGI $BWLD $JNS $ADHD $CSLT $RPRX $DDD #analytics #trader
Stockaholics
29 Oct 14 23:46:37
$MLCG closed up 166.67% today! Huge News: http://t.co/JxSMla9Afn $ANAC $ACTV $RPRX
Stockaholics
29 Oct 14 19:44:47
$MLCG closed up 166.67% today! Huge News: http://t.co/JxSMla9Afn $ANAC $ACTV $RPRX
Hector
29 Oct 14 16:41:28
RT @StockSignaling: Top Stocks (By Trading Liquidity): $SWHC $EOX $REXX $GPRE $AEGR $NLNK $JAKK $ANGI $BWLD $JNS $ADHD $CSLT $RPRX $DDD $CB…
Stock Signaling
29 Oct 14 16:31:41
Top Stocks (By Trading Liquidity): $SWHC $EOX $REXX $GPRE $AEGR $NLNK $JAKK $ANGI $BWLD $JNS $ADHD $CSLT $RPRX $DDD $CBSO #mkt #trader #spy
Stock Signaling
29 Oct 14 13:31:41
Top Stocks (By Trading Liquidity): $SWHC $EOX $REXX $GPRE $AEGR $NLNK $JAKK $ANGI $BWLD $JNS $ADHD $CSLT $RPRX $DDD $CBSO #finance #analyst
Stockaholics
29 Oct 14 12:07:50
Subscribe to our Penny Stock Newsletter, for the best penny stock picks, for FREE: http://t.co/5DC8vbG515 $ANAC $ACTV $RPRX
Stock Signaling
29 Oct 14 07:01:51
Top Stocks (By Trading Liquidity): $GPRE $AEGR $NLNK $JAKK $ANGI $BWLD $JNS $ADHD $CSLT $RPRX $DDD $CBSO $POWR $AFOP $IBIO #analytics #dow
Michele Ciani
29 Oct 14 05:58:28
$RPRX creating a base in the $6 zone, overspeculated, huge up potentiality
stockblaster14
29 Oct 14 03:42:19
Repros Therapeutics Inc (RPRX) 6.49 $RPRX Repros to Webcast Investor and Analyst Day on October 31st GlobeNews http://t.co/12jjcgDDSY
Stockaholics
28 Oct 14 23:12:30
After 371% Gains Our New Penny Stock Pick Is Coming Tomorrow! Get It Early: http://t.co/Nmnx36zJMR $ANAC $ACTV $RPRX
Stock Signaling
28 Oct 14 16:31:58
Top Stocks (By Trading Liquidity): $GPRE $AEGR $NLNK $JAKK $ANGI $BWLD $JNS $ADHD $CSLT $RPRX $DDD $CBSO $POWR $AFOP $IBIO #markets #spy
Henry Franco Bendeck
28 Oct 14 13:32:14
RT @StockSignaling: Top Stocks (By Trading Liquidity): $AEGR $NLNK $JAKK $ANGI $BWLD $JNS $ADHD $CSLT $RPRX $DDD $CBSO $POWR $AFOP $IBIO $C…
Stock Signaling
28 Oct 14 13:31:37
Top Stocks (By Trading Liquidity): $AEGR $NLNK $JAKK $ANGI $BWLD $JNS $ADHD $CSLT $RPRX $DDD $CBSO $POWR $AFOP $IBIO $CSIQ #nyse #analytics
Stocks Pastor
28 Oct 14 12:47:40
$RMTI, $RPRX events with FDA very close
Stocks Pastor
28 Oct 14 12:45:40
$RPRX $7 target almost reached. $6.80 from $6. FDA event very close. Do your DD
troymccall
28 Oct 14 10:23:04
RT @zbiotech: i hear for $RPRX analyst meeting on halloween big joe is gonna dress up as a CEO
zach
28 Oct 14 09:59:50
i hear for $RPRX analyst meeting on halloween big joe is gonna dress up as a CEO
Stock Signaling
28 Oct 14 07:01:50
Top Stocks (By Trading Liquidity): $AEGR $NLNK $JAKK $ANGI $BWLD $JNS $ADHD $CSLT $RPRX $DDD $CBSO $POWR $AFOP $IBIO $CSIQ #swingtrading
PsychoOnWallSt
28 Oct 14 06:56:30
$ZIOP $RPRX $GEVO top swings from blog
Stockaholics
28 Oct 14 06:48:00
After 371% Gains A Major New Penny Stock Pick Is Coming: http://t.co/1aBeBJdWkA $ANAC $ACTV $RPRX
stockblaster14
28 Oct 14 06:13:56
Repros Therapeutics Inc (RPRX) 6.63 $RPRX Repros to Webcast Investor and Analyst Day on October 31st GlobeNews http://t.co/MAap2h6aYC
lavina
28 Oct 14 06:12:35
RT @micheleciani: #biotech #buy #stocks $ALXA $NVAX $CPHI $OXGN $OCRX $ACST $AEZS $CYCC $CPRX $RPRX $EVOK $VSTM and others http://t.co/awqo…
Van Dinh
28 Oct 14 06:00:13
RT @micheleciani: #biotech #buy #stocks $ALXA $NVAX $CPHI $OXGN $OCRX $ACST $AEZS $CYCC $CPRX $RPRX $EVOK $VSTM and others http://t.co/awqo…
Michele Ciani
28 Oct 14 05:56:18
#biotech #buy #stocks $ALXA $NVAX $CPHI $OXGN $OCRX $ACST $AEZS $CYCC $CPRX $RPRX $EVOK $VSTM and others http://t.co/awqo444IZB
Michele Ciani
28 Oct 14 05:55:10
$RPRX bottomed. Will run up
DailyStockPicks
28 Oct 14 05:50:11
#virtualreality headsets will be the consumer tech gadget for 2015. $RPRX investors can profit from Spectra7 $SPVNF: http://t.co/UGK1Sij9xy
Don Fishback
28 Oct 14 04:35:02
Academic Algorithms:(95-100 Skew Difference) $ACM, $ALR, $NBS, $CYBX, $RPRX http://t.co/WbJSSNYQN7
OptionApps
28 Oct 14 04:35:02
Academic Algorithms:(95-100 Skew Difference) $ACM, $ALR, $NBS, $CYBX, $RPRX http://t.co/fCweeCb2FC
Yu Zhu
27 Oct 14 23:35:34
RT @ACInvestorBlog: $RPRX Just out: Buy rating on Repros Therapeutics with a $41 price target. http://t.co/6AwnXeN6Yw
				
				
By  +Follow September 17, 2013 8:01AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.